title: Increased Antiviral Treatment Among Hospitalized Children and Adults With Laboratory-Confirmed Influenza, 2010-2015.
abstract: (See the Editorial Commentary by Martin on pages 368-9.)Using population-based surveillance data, we analyzed antiviral treatment among hospitalized patients with laboratory-confirmed influenza. Treatment increased after the influenza A(H1N1) 2009 pandemic from 72% in 2010-2011 to 89% in 2014-2015 (P < .001). Overall, treatment was higher in adults (86%) than in children (72%); only 56% of cases received antivirals on the day of admission.
authors.affiliation: Epidemic Intelligence Service and Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia; ydg3@cdc.gov.|California Emerging Infections Program, Oakland.
authors.forename: Grace D
authors.initials: GD
authors.lastname: Appiah
authors.affiliation: Epidemic Intelligence Service and Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia.
authors.forename: Sandra S
authors.initials: SS
authors.lastname: Chaves
authors.affiliation: California Emerging Infections Program, Oakland.
authors.forename: Pam D
authors.initials: PD
authors.lastname: Kirley
authors.affiliation: Colorado Department of Public Health and Environment, Denver.
authors.forename: Lisa
authors.initials: L
authors.lastname: Miller
authors.affiliation: Connecticut Emerging Infections Program, Yale School of Public Health, New Haven.
authors.forename: James
authors.initials: J
authors.lastname: Meek
authors.affiliation: Departments of Pediatrics and Medicine, Emory University School of Medicine, and Atlanta Veterans Affairs Medical Center, Atlanta, Georgia.
authors.forename: Evan
authors.initials: E
authors.lastname: Anderson
authors.affiliation: Iowa Department of Health, Des Moines.
authors.forename: Oluwakemi
authors.initials: O
authors.lastname: Oni
authors.affiliation: Maryland Department of Health and Mental Hygiene, Baltimore.
authors.forename: Patricia
authors.initials: P
authors.lastname: Ryan
authors.affiliation: Michigan Department of Health and Human Services, Lansing.
authors.forename: Seth
authors.initials: S
authors.lastname: Eckel
authors.affiliation: Minnesota Department of Health, St Paul.
authors.forename: Ruth
authors.initials: R
authors.lastname: Lynfield
authors.affiliation: New Mexico Department of Health, Santa Fe.
authors.forename: Marisa
authors.initials: M
authors.lastname: Bargsten
authors.affiliation: New York State Department of Health, Albany; University of Rochester School of Medicine and Dentistry, Rochester, New York.
authors.forename: Shelley M
authors.initials: SM
authors.lastname: Zansky
authors.affiliation: Epidemic Intelligence Service and Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia.
authors.forename: Nancy
authors.initials: N
authors.lastname: Bennett
authors.affiliation: Ohio Department of Health, Columbus.
authors.forename: Krista
authors.initials: K
authors.lastname: Lung
authors.affiliation: Oklahoma Department of Health, Oklahoma City.
authors.forename: Christie
authors.initials: C
authors.lastname: McDonald-Hamm
authors.affiliation: Oregon Department of Public Health, Portland.
authors.forename: Ann
authors.initials: A
authors.lastname: Thomas
authors.affiliation: Rhode Island Department of Health, Providence.
authors.forename: Diane
authors.initials: D
authors.lastname: Brady
authors.affiliation: Vanderbilt University School of Medicine, Nashville, Tennessee; and.
authors.forename: Mary L
authors.initials: ML
authors.lastname: Lindegren
authors.affiliation: Vanderbilt University School of Medicine, Nashville, Tennessee; and.
authors.forename: William
authors.initials: W
authors.lastname: Schaffner
authors.affiliation: Utah Department of Health, Salt Lake City.
authors.forename: Mary
authors.initials: M
authors.lastname: Hill
authors.affiliation: Epidemic Intelligence Service and Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia.
authors.forename: Shikha
authors.initials: S
authors.lastname: Garg
authors.affiliation: Epidemic Intelligence Service and Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia.
authors.forename: Alicia M
authors.initials: AM
authors.lastname: Fry
authors.affiliation: Epidemic Intelligence Service and Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia; ydg3@cdc.gov app4@cdc.gov.
authors.forename: Angela P
authors.initials: AP
authors.lastname: Campbell
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000998:Antiviral Agents / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D015331:Cohort Studies; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D053118:Influenza A Virus, H1N1 Subtype; D007251:Influenza, Human / Q000188:drug therapy* / Q000453:epidemiology*; D007902:Length of Stay; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D053139:Oseltamivir / Q000627:therapeutic use*; D058873:Pandemics; D011446:Prospective Studies; D012189:Retrospective Studies; D012621:Seasons; D014481:United States / Q000453:epidemiology; D055815:Young Adult
chemical_list: D000998:Antiviral Agents; D053139:Oseltamivir
keywords: antiviral; influenza; oseltamivir.